Clinical Trial Update: BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study [Phase 3]

View source ↗

Summary

Phase 3 BENEFIT trial and its follow-up in newly diagnosed multiple sclerosis completed; results were posted on 2010-11-30 evaluating interferon beta-1b (Betase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)
• Betaseron (Interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2010-11-30